We investigated the frequency of nTreg in peripheral blood by epigenetic analysis of the TSDR, and explored the prognostic value of CD4+ TSDR-demethylated cells as a marker of Treg associated with cSCC development. The gene discussed is CD4; the disease is skin squamous cell carcinoma.